Journal of medical economicsHumansCost-Benefit AnalysisAustraliaChickenpoxChickenpox Vaccine
Development and validation of an agent-based cost-effectiveness model of varicella vaccination strategies in Australia.
Brent Hodgkinson, Paul Scuffham
Published: 202510.1080/13696998.2025.2577513
Abstract
AIMS: Varicella zoster virus (VZV) is highly infectious and initially presents as varicella (chickenpox, CP); following recovery VZV poses a lifetime risk of re-emergence as herpes zoster (shingles, HZ). At the time of this study, the Australian Nati…
Preview only. Read the full abstract at the source